HCM II Acquisition Corp. is a specialized special purpose acquisition company (SPAC) dedicated to identifying and merging with promising high-growth companies in the healthcare sector. With a seasoned management team that possesses extensive industry knowledge, HCM II is strategically positioned to capitalize on emerging trends and innovative solutions in the healthcare market. The firm aims to provide institutional investors with unique access to transformative healthcare opportunities, fostering potential value creation and long-term investment returns in a rapidly evolving industry.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.48 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $25.00M |
| Float | $21.05M |
| % Insiders | 0.00% |
| % Institutions | 0.17% |
Volatility is currently contracting